Liquid biopsy has the potential to provide information about cancers without invasive biopsy,
using circulating biomarkers. These include proteins, RNA and DNA. They can be used in …

The treatment of cancer has remarkably improved because of increased knowledge of the
molecular abnormalities that drive human cancer growth. This has led to the development of …

Introduction: Liquid biopsies have attracted considerable attention as potential diagnostic,
prognostic, predictive, and screening assays in oncology. The term liquid biopsies include …

Recently, the advent of therapies targeting genomic alterations has improved the care of
patients with certain types of cancer. While molecular targets were initially detected in …

The minimally—or non-invasive detection of circulating tumor-derived components in
biofluids, such as blood, liquid biopsy is a revolutionary approach with significant potential …

Detection of circulating nucleic acids, also referred to as liquid biopsy, has been evaluated
for detection of cancer in a variety of settings. We describe important clinical and …

Liquid biopsies of circulating tumor DNA offer a non-invasive tool with many potential
applications in oncology, including early cancer detection, profiling, disease prognosis …

The clinical utility of tissue biopsies in cancer management will continue to expand,
especially with the evolving role of targeted therapies.“Liquid biopsy” refers to testing a …

Imaging and image-guided procedures play an imperative role in the screening, diagnosis,
and surveillance of cancer. Although emerging imaging techniques now enable more …

Over the past decade, invasive techniques for diagnosing and monitoring cancers are slowly
being replaced by non-invasive methods such as liquid biopsy. Liquid biopsies have …